Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma

Volume: 6, Issue: 3, Pages: 425 - 425
Published: Mar 1, 2020
Abstract

Importance

All patients who develop multiple myeloma have a preceding asymptomatic expansion of clonal plasma cells, clinically recognized as monoclonal gammopathy of undetermined significance or smoldering multiple myeloma (SMM). During the past decade, significant progress has been made in the classification and risk stratification of SMM.

Observations

This review summarizes current clinical challenges and discusses available...
Paper Details
Title
Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma
Published Date
Mar 1, 2020
Volume
6
Issue
3
Pages
425 - 425
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.